Instituto de Salud Global de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2024

  1. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

2023

  1. Performance evaluation of human cough annotators: optimal metrics and sex differences

    BMJ open respiratory research, Vol. 10, Núm. 1

2022

  1. Data on the effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19.

    CORA.Repositori de Dades de Recerca

2021

  1. The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

    EClinicalMedicine, Vol. 32

  2. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2018

  1. Targeting cattle for malaria elimination: Marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulation

    Parasites and Vectors, Vol. 11, Núm. 1

2017

  1. Pilot study of a slow-release ivermectin formulation for malaria control in a pig model

    Antimicrobial Agents and Chemotherapy

2015

  1. Falsified antimalarials: A minireview

    Expert Review of Anti-Infective Therapy, Vol. 13, Núm. 4, pp. 505-509

  2. Screening for an ivermectin slow-release formulation suitable for malaria vector control

    Malaria Journal, Vol. 14, Núm. 1